Chapter 24: High-Risk Newborn: Acquired and Congenital Conditions
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
High-Risk Newborn: Acquired and Congenital Conditions clinical overview explores the complex management of neonates facing acquired and congenital health challenges, emphasizing the critical role of neonatal nursing in stabilizing high-risk infants. The discussion begins with acute respiratory complications, detailing the physiological impact of neonatal asphyxia and the progression of metabolic and respiratory acidosis, while also differentiating between transient tachypnea caused by retained fetal lung fluid and the severe obstructive pathology of meconium aspiration syndrome (MAS). It addresses the life-threatening nature of persistent pulmonary hypertension of the newborn (PPHN) and the necessity of prompt resuscitative measures focused on effective ventilation. A significant portion of the material is dedicated to hyperbilirubinemia, specifically distinguishing pathologic jaundice from physiological norms and outlining the risks of bilirubin toxicity leading to permanent neurological impairment known as kernicterus. Therapeutic interventions like phototherapy and exchange transfusions are analyzed alongside essential nursing precautions for infant safety and thermal regulation. The chapter further investigates the systemic threat of sepsis neonatorum, highlighting subtle diagnostic signs and the urgency of broad-spectrum antibiotic therapy. Detailed attention is given to the unique metabolic risks faced by infants of diabetic mothers, including macrosomia and profound hypoglycemia, as well as the specialized care required for neonatal abstinence syndrome (NAS) resulting from prenatal drug exposure. Finally, the text provides an essential guide to identifying and managing major congenital anomalies, spanning from gastrointestinal malformations and neural tube defects to complex cardiac conditions such as Tetralogy of Fallot and transposition of the great arteries, while also covering genetic screenings for metabolic disorders like phenylketonuria (PKU).